Skip to main content

Table 2 PRESIDE trial participant timeline

From: The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care

 

Trial period

Enrolment

Allocation to intervention

Post-allocation

Time point

0 weeks

2–3 weeks

4 weeks

8 weeks

12 weeks

26 weeks

Post-26 weeks

Enrolment

X

      

    Eligibility screen

X

      

    Informed consent

X

      

    DNA collection

X

      

    Allocation to intervention

 

X

     

Interventions

    Antidepressant prescribing report

 

X

     

    Full clinical PGx report

      

X

Assessments

    Demographics

X

      

    PHQ-9

X

 

X

X

X

X

 

    FISBER

X

 

X

X

X

X

 

    AQoL-4D

X

   

X

X

 

    MARS-5

X

 

X

X

X

X

 

    COVID-19 QoL and Mental Health Impact Scale

     

X

 

    Resource use questionnaire

X

   

X

X

 

    GP record audit

     

X

 

    MBS and PBS data

      

X